Monthly Archives: March 2017
Classification of Portal Vein Thrombosis in Cirrhosis
I believe that some further comment is appropriate about the need of a new classification of portal vein thrombosis (PVT) in patients with cirrhosis, as discussed in the interesting paper recently published in Gastroenterology.1 Continue reading
Information for Authors and Readers
Gastroenterology is the premiere journal in the field of gastrointestinal disease and is led by an internationally renowned board of editors. As the official journal of the AGA Institute, Gastroenterology delivers up-to-date and authoritative coverag… Continue reading
The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association
The purpose of this review is to evaluate the risks associated with long-term use of proton pump inhibitors (PPIs), focusing on long-term use of PPIs for three common indications: gastroesophageal reflux disease (GERD), Barrett’s esophagus (BE), and … Continue reading
Exam 1: Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-Analysis
Abnormal Liver Tests and Persistent Lactic Acidosis in an 18-Year-Old Woman
Question: An 18-year-old woman with past medical history of poorly controlled type 1 diabetes mellitus presented to the hospital with abdominal pain, nausea, vomiting, diaphoresis, and light headedness. Continue reading
Gastrointestinal Bleeding and Direct Oral Anticoagulants amongst Patients with Atrial Fibrillation in the ‘Real World’
Gastrointestinal Bleeding and Direct Oral Anticoagulants Amongst Patients With Atrial Fibrillation in the “Real World”
The pivotal aim of oral anticoagulation in atrial fibrillation (AF) is prevention of AF-related thromboembolic strokes. The vitamin K antagonists (eg, warfarin) have been the standard of care for many years, reducing both stroke and mortality rates by … Continue reading